Loading clinical trials...
Loading clinical trials...
Benign hypertrophy of the prostate (BPH) is the most frequent pathology in the urinary tract of middle-aged men. In recent years, to enable BPH treatment with larger volumes and to reduce the risk of ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT07377929 · Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms
NCT05308017 · Benign Prostatic Hypertrophy
NCT04398420 · Benign Prostatic Hypertrophy
NCT00427219 · Benign Prostatic Hypertrophy
NCT02051036 · BPH, Benign Prostatic Hyperplasia, and more
CH Grasse - urologie
Grasse, Alpes-maritimes
CHU de Nice - Urologie
Nice, Alpes-Maritimes
CH privé St Brieuc
Saint-Brieuc, Cote D'armor
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions